Delivery Order SPE2DB22D3019-SPE2DB25FK3UP

Award Date 6/13/25
Potential Completion Date 6/16/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $2,621.97 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 units of OXCARBAZEPINE ER 600 MG TABLET. The contract has an ultimate completion date of June 12, 2025 and is not set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract is for the delivery of OXCARBAZEPINE ER 150 MG TABLET 100S, with a ceiling value of $2,028.63 and a performance period that runs through May 16, 2025. The contract is a firm fixed price, non-set-aside award. Amerisourcebergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,629.05 firm fixed-price delivery order is for the supply of 100 units of the medication OXCARBAZEPINE ER 600 MG TABLET. The contract has an ultimate completion date of June 10, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,541.50 Firm Fixed Price Delivery Order is for the supply of 4566514910 OXCARBAZEPINE ER 300 MG TABLET 100S, with a period of performance through November 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division located in Conshohocken, Pennsylvania. The contract, valued at $1,345.12, is for the provision of 4564249689 - OXCARBAZEPINE 300 MG/5 ML SUSP 250ML, a pharmaceutical product. This delivery order is issued under an existing indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that...
This is a Delivery Order (DO) federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, is for the delivery of OXCARBAZEPINE 300 MG/5 ML SUSP 250ML, a neurological medication. The contract has a ceiling value of $3,523.92 and a completion date of May 21, 2025. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $48,000 to Amerisourcebergen Drug Corporation for the supply of 100 boxes containing 150mg Oxcarbazepine tablets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 23, 2023 under the terms of the order. The Defense Logistics Agency routinely issues such requirements to established pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Oxycodone-Acetaminophen 10-325 tablets. The $1,663.68 firm fixed-price contract has a completion date of May 6, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,739.95 and covers the delivery of a range of pharmaceutical products and medical supplies, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The contract is a firm fixed-price, non-set-aside arrangement...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,508.13 and a performance period through May 2025. It is a firm fixed-price contract for the delivery of various pharmaceutical and medical products, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The...
  • SPE2DB22D3019
    Indefinite Delivery Contract
  • SPE2DB22D3019-SPE2DB25FK3UP
    Delivery Order

This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Oxcarbazepine 600 mg tablets, a neurological medication, with a ceiling value of $1,792.41 and a performance period through June 2025. The contract is not set aside and is a firm fixed-price type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military and government healthcare programs.

Generated 9/12/25, 10:48 AM